Dr Reddy’s says ‘slight’ delay in commercial rollout of Sputnik V vaccine
Dr Reddy’s has said there is a “slight postponement” in the timeline of the commercial launch of Sputnik V coronavirus vaccine due to dependency on...
Continue ReadingExclusive webinar organised by Gubba in collaboration with Darda associates on ‘ Production linked incentive scheme’
PLI for API/KSM/DI [PLI 1.0] was launched last year in March 2020 for the incentive outlay of INR 6,940 crores for which 47 approvals have...
Continue ReadingIRM India Affiliate To Strengthen Risk-Readiness In The Indian Pharmaceutical Sector
Globally, the pharma industry has undergone a rapid change over the last year, with the demand generated from the COVID pandemic overshadowing other treatment areas...
Continue ReadingBayer, Zydus extend pharma JV by 3 years
German chemical and pharma major Bayer and Ahmedabad-based Cadila Healthcare on Monday extended their pharmaceuticals joint venture by three years from June 2021. The companies...
Continue ReadingOvercoming the Challenges of API Complexity
Pharmaceutical drug molecules are becoming increasingly complex, posing challenges in formulation development and manufacturing. This is particularly true of small molecule drug APIs and peptides,...
Continue ReadingZydus Cadila, gets permission for clinical trials of antibodies cocktail to treat Covid-19
The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of Covid-19 has been given permission...
Continue ReadingThis pharma firm in Gurugram first manufactured the drug that treats black fungus in India
While patients jostle to find the drug, Liposomal Amphotericin B, which treats black fungus, workers at Lifecare Innovations, a Gurugram-based pharmaceutical firm, have been working...
Continue ReadingBiological E’s Corbevax could be the most affordable Covid vaccine in India
Biological E’s Corbevax, which is undergoing Phase 3 trials, could well be the most affordable vaccine in India priced at below Rs 500 for two...
Continue ReadingPharmEasy acquires Medlife, becomes India’s largest e-pharma company
PharmEasy has acquired Medlife for an undisclosed amount, the e-pharmacy unicorn said on Tuesday. The deal will make PharmEasy the largest player in the domestic...
Continue Reading